Growth at Bosch Packaging Technology continues at an above-average rate for the market. The company expects order books to peak at over 900 million euros in 2012. This will be accompanied by a twelve percent increase in annual sales. “All of the
available economic data indicates continued growth on a global scale,” reported Friedbert Klefenz, President of Bosch Packaging Technology, speaking at Achema in Frankfurt, the industry's leading exhibition for process technology. “We expect to see very dynamic developments in Asia, the Indian subcontinent, Latin America and Africa – especially in generics, which will significantly gain importance
compared to conventional brand-name drugs.”
The international position of Bosch Packaging Technology which currently generates about 90 percent of its sales outside of Germany, ensures increasing independence from regional economic fluctuations. At the same time, diversification in the pharmaceutical sector supports consistent expansion of the Bosch portfolio along the entire value chain. With the takeover of Eisai Co., Ltd. (now Eisai Machinery, Tokyo, Japan) in April 2012 and the acquisitions of Hüttlin GmbH (Schopfheim, Germany) and Manesty (now Bosch Packaging Technology Ltd., Knowsley, United Kingdom) in summer 2011, Bosch Packaging Technology further expanded its inspection and process technology portfolio.